The 2024-2025 flu vaccine is trivalent, targeting A/H1N1, A/H3N2, and B/Austria strains, with new recommendations for solid-organ transplant recipients. FluMist, a self-administered flu vaccine, is ...

CDC data show SARS-CoV-2 and RSV continue to impact younger children and older adults, with significant hospitalization and mortality rates across the US.

Nearly three fourths of infants born during the 2023-2024 respiratory syncytial virus (RSV) season received protection with either nirsevimab or exposure to maternal RSVpreF, with maternal RSVpreF ...

JONESBORO, Ark. (KAIT) - The Arkansas Department of Health tracks viral respiratory diseases, including influenza, COVID-19, and respiratory syncytial virus (RSV) each week. On Thursday, May 1, the ...

Nirsevimab is a monoclonal antibody crucial for preventing severe RSV in infants and young children. A nationwide shortage prompted a revised allocation strategy prioritizing VFC-eligible infants in ...

LEXINGTON, Ky. (WKYT) - As we near the end of 2024, respiratory illnesses like COVID and the flu could be on the rise. “COVID seems to not have that predictable pattern that we see with flu and RSV ...

Cooler temperatures are expected in Iowa soon, and with it, another season of respiratory viral illnesses. The time for the cold-weather spread of COVID-19, influenza and respiratory syncytial virus ...

"Additional efforts are needed to increase infant protection against severe RSV through maternal or infant immunization," the authors wrote. HealthDay News — Overall, 29% of infants born during ...

An estimated 29% of infants born from October 2023 to March 2024 were immunized against RSV. Preliminary data showed the immunization rate rose to 57% of infants born from April 2024 to March 2025.

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Researchers studied real-world data on the effectiveness ...